Abstract: The example embodiments are directed to a system and method for generating and controlling a user interface for managing a software development lifecycle of an industrial software application. In one example, the method includes developing a software application via a user interface, storing an application file representing the developed software application in a code repository associated with the user interface, testing the application file to determine whether the developed software application successfully satisfies requirements for a platform, and deploying the successfully tested application file from the code repository to the platform and activating the application on the platform, in response to receiving a user request.

Abstract: The example embodiments are directed to a system and method for generating and controlling a user interface for managing a software development lifecycle of an industrial software application. In one example, the method includes developing a software application via a user interface, storing an application file representing the developed software application in a code repository associated with the user interface, testing the application file to determine whether the developed software application successfully satisfies requirements for a platform, and deploying the successfully tested application file from the code repository to the platform and activating the application on the platform, in response to receiving a user request.

Abstract: The example embodiments are directed to a system and method for generating and controlling a user interface for managing a software development lifecycle of an industrial software application. In one example, the method includes developing a software application via a user interface, storing an application file representing the developed software application in a code repository associated with the user interface, testing the application file to determine whether the developed software application successfully satisfies requirements for a platform, and deploying the successfully tested application file from the code repository to the platform and activating the application on the platform, in response to receiving a user request.

Abstract: The example embodiments are directed to a system and method for generating and controlling a user interface for managing a software development lifecycle of an industrial software application. In one example, the method includes displaying the user interface for developing an application, determining software components available for developing the application and displaying representations of the software components via the user interface, receiving a selection of at least one software component from among the available software components, via the user interface, and adding the selected at least one software component to a development workspace of the user interface, configuring the selected at least one software component to work with data processed by the application, and generating an application file for the application including the at least one configured software component and storing the application file in a code repository.

Abstract: Compounds of the formula: where the formula variables are as defined herein, are disclosed that advantageously inhibit or block the biological activity of the HIV protease. These compounds, as well as pharmaceutical compositions containing these compounds, are useful for treating patients or hosts infected with the HIV virus. Intermediates and synthetic methods for preparing such compounds are also described.

Abstract: Compounds of the formula: where the formula variables are as defined herein, are disclosed that advantageously inhibit or block the biological activity of the HIV protease. These compounds, as well as pharmaceutical compositions containing these compounds, are useful for treating patients or hosts infected with the HIV virus. Intermediates and synthetic methods for preparing such compounds are also described.

Abstract: Indazole compounds that modulate and/or inhibit the activity of certain protein kinases are described. These compounds and pharmaceutical compositions containing them are capable of mediating tyrosine kinase signal transduction and thereby modulate and/or inhibit unwanted cell proliferation. The invention is also directed to the therapeutic or prophylactic use of pharmaceutical compositions containing such compounds, and to methods of treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation, such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, and psoriasis, by administering effective amounts of such compounds.